- $19.37m
- $27.63m
- $28.17m
- 34
- 46
- 69
- 48
Annual income statement for Marpai, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 14.2 | 24.3 | 37.2 | 28.2 |
| Cost of Revenue | |||||
| Gross Profit | 0 | 3.94 | 7.21 | 12.9 | 9.11 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 3.37 | 30.1 | 51.3 | 65.1 | 49.1 |
| Operating Profit | -3.37 | -15.9 | -27 | -28 | -21 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -3.87 | -16.1 | -27 | -29 | -23.3 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -3.87 | -16 | -26.5 | -28.8 | -22.1 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -3.87 | -16 | -26.5 | -28.8 | -22.1 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -3.87 | -16 | -26.5 | -28.8 | -22.1 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -1.08 | -6.35 | -5.2 | -3.99 | -1.51 |
| Dividends per Share |